diagnosi
infecti
diseas
requir
activ
commun
clinician
clinic
laboratori
personnel
usual
form
consult
clinician
laboratori
director
call
directli
laboratori
technologist
arriv
correct
diagnosi
time
fashion
begin
acquisit
adequ
clinic
specimen
blood
cerebrospin
fluid
urin
respiratori
secret
bronchoalveolar
lavag
fece
etc
transport
laboratori
appropri
contain
specimen
molecular
diagnost
test
sometim
requir
differ
method
transport
preserv
regular
specimen
ensur
techniqu
use
effici
detect
suspect
infecti
agent
classic
diagnost
principl
clinic
medicin
still
appli
use
molecular
method
diagnosi
patient
popul
evalu
clinic
epidemiolog
case
definit
creat
test
paramet
sensit
specif
predict
valu
defin
likewis
understand
concept
screen
versu
confirmatori
test
also
import
three
major
step
perform
molecular
assay
specimen
process
nucleic
acid
amplif
hybrid
product
detect
nolt
caliendo
pers
et
al
process
specimen
one
import
step
success
detect
nucleic
acid
protocol
vari
depend
specimen
receiv
specimen
matrix
play
import
role
nucleic
acid
extract
owe
presenc
extran
materi
matric
could
potenti
interfer
molecular
assay
perform
wide
known
exampl
interfer
presenc
taq
polymeras
inhibitor
nucleic
acid
extract
lead
falseneg
result
nucleic
acid
extract
protocol
usual
cumbersom
autom
rel
challeng
howev
sever
instrument
design
clinic
laboratori
autom
extract
protocol
incorpor
autom
also
incorpor
nucleic
acid
amplif
method
includ
convent
realtim
polymeras
chain
reaction
pcr
branch
dna
isotherm
technolog
obviat
usual
thermal
cycl
potenti
speed
time
requir
amplif
autom
platform
howev
decreas
cycl
time
chang
quickli
temperatur
requir
differ
pcr
cycl
realtim
pcr
system
usual
coupl
autom
detect
system
also
vari
complex
instrument
also
capabl
complet
autom
includ
extract
nucleic
acid
amplif
detect
system
tabl
present
summari
techniqu
avail
detect
nucleic
acid
infecti
agent
fortun
biotechnolog
boom
late
earli
fuel
develop
highli
autom
nucleic
test
method
import
implic
identif
infecti
pathogen
human
specimen
moneck
ehricht
one
technolog
commonli
refer
realtim
pcr
gain
consider
popular
method
combin
nucleic
acid
amplif
fluoresc
detect
amplifi
product
close
system
mors
relman
et
al
hjell
et
al
aragon
et
al
promulg
realtim
pcr
import
test
platform
clinic
microbiolog
catapult
us
homeland
secur
effort
produc
rapid
reliabl
test
method
identifi
potenti
agent
bioterror
laboratori
respons
network
lrn
integr
group
public
health
arm
forc
privat
referr
laboratori
creat
center
diseas
control
prevent
cdc
serv
refer
laboratori
network
identifi
confirm
agent
bioterror
short
period
scientist
cdc
success
develop
number
realtim
pcr
assay
detect
agent
bioterror
assay
avail
mani
lrn
laboratori
therefor
molecular
tool
improv
initi
diagnosi
emerg
reemerg
infecti
diseas
especi
pathogen
uncultiv
difficult
isol
clinic
laboratori
nolt
caliendo
pers
et
al
addit
convent
diagnost
test
infecti
agent
slow
sensit
expens
unavail
therefor
sinc
identif
sever
pathogen
obtain
molecular
techniqu
contribut
primarili
diagnosi
infecti
agent
relman
nucleic
assay
gold
standard
sever
infecti
agent
includ
hepat
c
viru
hcv
enteroviru
bordetella
pertussi
herp
simplex
viru
hsv
context
herp
enceph
chlamydia
trachomati
other
costeffect
undoubtedli
extrem
import
factor
introduc
molecular
diagnost
clinic
laboratori
replac
convent
techniqu
best
exampl
common
bacteri
pathogen
requir
addit
identif
sensit
test
guid
clinician
choos
effect
antibiot
one
promis
platform
clinic
microbiolog
laboratori
molecular
diagnost
use
multiplex
technolog
loeffelholz
smithn
et
al
abil
realtim
pcr
amplifi
detect
product
amplifi
use
specif
probe
time
allow
multipl
amplif
clinic
sampl
design
primer
critic
step
multiplex
pcr
effici
specif
amplif
compromis
realtim
multiplex
coupl
pcr
liquidstain
microarray
provid
multiplex
detect
pathogen
clinic
syndrom
fdaapprov
diagnost
product
alreadi
avail
viral
respiratori
pathogen
could
imagin
use
multiplex
system
diagnos
enter
pathogen
nosocomi
infect
includ
identif
gene
respons
antibiot
resist
accord
hospit
epidemiolog
data
pathogen
central
nervou
system
hemorrhag
fever
sepsi
could
also
consid
inclus
emerg
reemerg
infecti
agent
syndromebas
diagnost
product
establish
true
incid
preval
highli
neglect
infecti
diseas
furthermor
numer
report
describ
util
userfriendli
technolog
rapid
sameday
accur
detect
mani
emerg
new
reemerg
pathogen
well
pathogen
commonli
encount
medic
practic
search
articl
publish
journal
clinic
microbiolog
evalu
realtim
pcr
test
method
pathogen
detect
andor
identif
gene
mutat
associ
antimicrobi
resist
pathogen
reveal
articl
among
articl
describ
assay
lightcycl
instrument
roch
diagnost
corpor
indianapoli
describ
assay
abi
prism
instrument
appli
biosystem
foster
citi
ca
describ
assay
smartcycl
instrument
cepheid
sunnyval
ca
describ
assay
icycl
instrument
biorad
laboratori
hercul
ca
avail
nucleic
technolog
realtim
pcr
along
convent
stain
cultur
method
immunoassay
provid
laboratori
mani
size
comprehens
respons
approach
detect
commonli
encount
emerg
reemerg
pathogen
clinic
present
concern
patient
infect
common
virus
caus
cutan
vesicular
lesion
hsv
varicellazost
viru
vzv
enteroviru
dissemin
vaccinia
viru
follow
smallpox
vaccin
might
mimic
patient
smallpox
anoth
complic
featur
recipi
smallpox
vaccin
may
develop
erythema
multiform
also
present
vesicular
lesion
experi
use
realtim
pcr
assay
one
rapidli
discrimin
among
possibl
analyt
specif
reagent
asr
kit
detect
hsv
vzv
lightcycl
instrument
avail
least
two
vendor
realart
hsv
kit
realart
vzv
pcr
kit
artu
lightcycl
herp
simplex
viru
lightcycl
vzv
roch
diagnost
corpor
kit
also
avail
test
vzv
realart
vzv
pcr
kit
artu
abi
prism
instrument
research
use
assay
roch
lightcycl
instrument
routin
detect
hsv
vzv
develop
inhous
realtim
pcr
assay
poxvirus
includ
variola
viru
use
lightcycl
instrument
assay
invalu
provid
rapid
result
especi
militari
personnel
develop
cutan
vesicular
lesion
complic
receiv
smallpox
vaccin
assign
area
world
signific
risk
bioterror
event
importantli
homebrew
realtim
assay
develop
discrimin
among
sever
poxvirus
use
identif
viremia
recent
case
monkey
poxviru
diseas
patient
upper
midwest
asr
detect
variola
viru
lightcycl
instrument
also
avail
artu
realart
orthopox
pcr
kit
west
nile
viru
rna
viru
famili
flavivirida
predilect
central
nervou
system
associ
signific
morbid
mortal
first
human
case
west
nile
viru
infect
occur
northeastern
unit
state
summer
sinc
diseas
progress
relentlessli
east
west
across
continent
unit
state
yet
effect
therapi
defin
tradit
summer
earli
fall
unit
state
viral
central
nervou
system
diseas
frequent
caus
enteroviru
region
unit
state
west
nile
viru
infect
must
also
consid
time
year
hsv
caus
enceph
time
year
antivir
therapi
avail
effect
therefor
rule
hsv
infect
prioriti
especi
enceph
encount
realtim
pcr
replac
viral
cultur
gold
standard
rapid
accur
detect
hsv
cerebrospin
fluid
mention
previous
asr
kit
detect
hsv
avail
artu
roch
artu
also
kit
use
test
enteroviru
realart
enteroviru
rtpcr
kit
lightcycl
instrument
limit
studi
shown
pcr
detect
west
nile
viru
cerebrospin
fluid
less
sensit
immunoassay
immunoglobulin
antibodi
current
referr
public
health
laboratori
capabl
perform
immunoassay
least
two
compani
offer
asr
kit
realtim
pcr
realart
wnv
rtpcr
kit
artu
lightcycl
wnv
detect
kit
roch
appli
scienc
lightcycl
platform
effect
antivir
therapi
becom
avail
rapid
onsit
diagnosi
west
nile
viru
diseas
area
endem
may
desir
one
import
lesson
learn
winter
outbreak
sever
acut
respiratori
syndrom
sar
earli
identif
quarantin
individu
suspect
case
sar
essenti
control
diseas
especi
institut
set
effect
approach
toward
control
communic
infecti
diseas
add
credenc
concept
similar
measur
effect
control
prevent
nosocomi
vre
methicillinresist
staphylococcu
aureu
mrsa
outbreak
laboratori
test
avail
detect
sar
coronaviru
sar
cov
much
outbreak
etiolog
agent
confirm
earli
march
eventu
realtim
pcr
test
develop
avail
commerci
least
two
manufactur
use
sever
realtim
pcr
test
platform
realart
hpacoronaviru
rtpcr
kit
artu
use
lightcyl
instrument
abi
prism
instrument
rotorgen
instrument
lightcycl
sar
cov
roch
diagnost
corpor
use
lightcycl
instrument
outbreak
import
rule
treatabl
influenza
viru
type
b
infect
whose
clinic
present
mimic
sar
cov
rapid
antigen
test
detect
influenza
viru
type
b
rel
easi
perform
may
use
local
set
detect
case
influenza
howev
test
lack
sensit
infect
due
influenza
viru
type
b
treatabl
rapid
onsit
diagnost
capabl
import
recent
realtim
pcr
assay
use
lightcycl
platform
demonstr
much
greater
sensit
antigen
detect
respect
detect
influenza
viru
type
infect
follow
sar
outbreak
mani
lrn
member
laboratori
develop
capabl
detect
sar
cov
anoth
outbreak
occur
public
health
laboratori
network
facilit
laboratori
diagnosi
case
especi
test
local
level
avail
prognosi
infecti
diseas
also
significantli
affect
avail
molecular
techniqu
viral
load
sever
chronic
infect
human
immunodefici
viru
hiv
human
papillomaviru
hepat
c
bk
viru
cytomegaloviru
play
import
role
predict
better
wors
outcom
need
start
specif
antivir
therapi
improv
surviv
humar
et
al
mellor
et
al
reidn
et
al
walsh
et
al
viral
bacteri
quantif
molecular
method
could
also
use
futur
differenti
mild
subclin
infect
diseas
caus
agent
certain
condit
microarray
collect
microscop
featur
usual
dna
probe
target
molecul
produc
quantit
qualit
data
miller
tang
inde
diagnosi
infecti
diseas
often
qualit
presenc
absenc
pathogen
although
quantit
data
becom
numer
certain
condit
hivimmunodefici
syndrom
acquir
hepat
c
microarray
platform
classifi
follow
print
synthes
situ
highdens
bead
network
electron
suspens
liquid
bead
loeffelholz
miller
tang
microarray
platform
abil
multiplex
characterist
becom
indispens
diagnosi
infecti
diseas
approach
probe
dna
sequenc
bound
solid
surfac
array
target
nucleic
acid
detect
probe
synthes
immobil
microscop
spot
report
platform
suspens
bead
probabl
offer
practic
technolog
clinic
microbiolog
lab
loeffelholz
miller
tang
univers
heel
set
avail
userdefin
applic
easili
implement
flexibl
therefor
use
widerang
multiplex
pcr
follow
microarray
provid
excel
platform
rapid
effici
identif
bacteri
viral
fungal
pathogen
mikhailovich
et
al
diagnosi
bacteri
infect
microarray
also
incorpor
clinic
laboratori
rapid
detect
character
mrsa
determin
antimicrobi
drug
resist
sever
pathogen
enterococcu
mycobacterium
tuberculosi
diagnosi
sepsi
mancini
et
al
aragon
et
al
moneck
ehricht
sever
difficult
problem
remain
microarray
wide
use
clinic
set
includ
preand
postanalyt
variabl
type
clinic
specimen
matric
extract
techniqu
label
qualiti
control
miller
tang
introduct
microbiolog
laboratori
addit
diagnost
test
base
molecular
technolog
depend
heavili
autom
mani
molecular
test
remain
difficult
complex
lengthi
problem
process
interpret
sampl
biosurveil
becom
import
health
prioriti
increas
risk
emerg
reemerg
patholog
effect
human
popul
sintchenko
gallego
potenti
consequ
largescal
epidem
epidem
econom
social
environment
profound
evidenc
global
spread
coronaviru
associ
sever
acut
respiratori
syndrom
tradit
biosurveil
reli
heavili
diseas
report
clinic
laboratori
local
state
feder
healthcar
organ
sintchenko
gallego
clinic
diagnos
case
confirm
use
standard
microbiolog
method
serolog
marker
cultur
follow
biochem
identif
necessari
dnabas
type
method
pure
isol
obtain
result
method
describ
slow
insensit
tradit
biosurveil
improv
electron
report
extent
increas
proport
diagnos
case
report
case
occur
commun
panack
et
al
effler
et
al
hand
factor
includ
variabl
case
definit
clinic
laboratori
criteria
screen
practic
contact
track
method
qualiti
perform
diagnost
test
use
second
surveil
system
said
syndrom
base
collect
vast
amount
data
variou
servic
includ
emerg
depart
intens
care
unit
icu
admiss
hospit
system
clinic
laboratori
sintchenko
gallego
bravata
et
al
lewi
et
al
inde
purpos
system
play
role
alarm
signal
model
obtain
time
move
away
normal
state
normal
state
determin
collect
data
creat
baselin
given
area
commun
wang
et
al
berger
et
al
expect
specif
system
rather
low
improv
combin
syndrom
surveil
system
laboratori
surveil
sintchenko
gallego
buehler
et
al
weber
pitrak
latest
gener
surveil
base
genom
surveil
system
essenti
base
develop
rapid
molecular
test
appli
diagnosi
infecti
diseas
techniqu
base
molecular
subtyp
increas
sensit
specif
investig
epidem
level
hospit
local
state
nation
hedberg
besser
moneck
et
al
mellmann
et
al
similarli
modern
type
method
base
direct
data
sequenc
power
softwar
analyz
gene
cluster
genet
evolut
also
made
possibl
detect
possibl
epidem
new
pathogen
reemerg
agent
sintchenko
gallego
typic
exampl
includ
surveil
system
influenza
virus
sever
acut
respiratori
syndrom
power
molecular
techniqu
use
isol
modern
biomonitor
system
import
element
includ
tradit
epidemiolog
tool
newli
develop
computerbas
system
complet
integr
microbi
profil
merg
epidemiolog
surveil
spatial
surveil
depend
use
system
geograph
inform
network
global
laboratori
would
provid
exquisit
comprehens
view
potenti
biotherapi
urwin
maiden
casadeval
relman
rei
et
al
oconnor
et
al
layn
beugelsdijk
heymann
rodier
nanotechnolog
broad
term
encompass
sever
disciplin
techniqu
current
major
impact
health
care
purpos
review
nanobiotechnolog
applic
molecular
diagnost
discuss
nanotechnolog
studi
control
manipul
matter
atom
molecular
scale
johnson
et
al
materi
use
nm
less
least
one
dimens
materi
hand
molecular
diagnosi
essenti
element
develop
person
medicin
thu
present
punctual
perform
diagnost
procedur
report
focus
applic
sever
technolog
clinic
laboratori
set
differ
interrelationship
nanotechnolog
molecular
diagnost
role
nanomedicin
person
medicin
shown
fig
nanofluid
network
isol
analysi
biomolecul
nucleic
acid
protein
network
use
nanotub
isol
molecul
detect
molecul
trap
electrodebas
system
volum
requir
test
small
compar
requir
convent
instrument
turnaround
time
significantli
reduc
jain
whenev
singl
molecul
dna
move
nanotub
electr
current
chang
abruptli
current
return
refer
valu
dna
molecul
exit
nanotub
nanofluid
technolog
expect
wide
applic
system
biolog
person
medicin
pathogen
detect
drug
develop
clinic
research
gold
nanoparticl
nanocryst
also
call
quantum
dot
magnet
nanoparticl
main
exampl
categori
gold
nanoparticl
rang
nm
function
varieti
biomolecul
includ
antibodi
nucleic
acid
peptid
protein
carbohydr
thu
gold
nanoparticl
better
optic
absorpt
scatter
properti
uniqu
properti
known
plasma
reson
like
nanocryst
see
next
section
optic
properti
modifi
chang
size
shape
composit
hand
surfac
nanocryst
also
function
nucleic
acid
antibodi
protein
peptid
allow
adapt
sever
diagnost
platform
bruchez
et
al
hotz
michalet
et
al
magnet
nanoparticl
made
iron
incorpor
copolym
bead
surfac
charg
bead
manipul
polym
coat
enhanc
nonspecif
protein
adsorpt
surfac
bead
increas
specif
assay
johnson
et
al
jain
nanobiosensor
nanosensor
allow
detect
chemic
biolog
materi
materi
extrem
sensit
jain
prototyp
sensor
demonstr
detect
nucleic
acid
protein
ion
sensor
oper
liquid
gaseou
phase
allow
use
differ
downstream
applic
sensor
inexpens
manufactur
portabl
thu
serv
even
base
implement
implant
devic
detect
monitor
technolog
provid
altern
approach
pcr
complement
current
dna
protein
microarray
method
use
method
necessari
label
copi
target
molecul
advantag
cantilev
provid
fast
unlabel
recognit
specif
dna
sequenc
singlenucleotid
polymorph
oncogen
genotyp
nanocantilev
could
crucial
design
new
class
ultrason
sensor
detect
virus
bacteria
pathogen
gupta
et
al
final
realtim
cantilev
biosensor
provid
continu
monitor
clinic
paramet
person
medicin
viru
particl
biolog
nanoparticl
give
exampl
hsv
adenoviru
use
trigger
assembl
nanomagnet
bead
nanobiosensor
clinic
relev
virus
perez
et
al
thu
techniqu
offer
possibl
detect
five
viru
particl
ml
serum
sampl
system
advantag
increas
sensit
compar
enzymelink
immunosorb
assay
elisa
base
method
well
improv
pcrbase
detect
less
expens
faster
fewer
artifact
microrna
mirna
repres
recent
uncov
class
small
noncod
rna
nucleotid
function
posttranscript
regul
gene
express
mirna
code
separ
gene
local
nonprotein
code
part
genom
microrna
predict
regul
human
gene
griffithsjon
et
al
malumbr
small
noncod
rna
bind
target
messeng
rna
mrna
untransl
region
utr
code
sequenc
cd
region
act
neg
regul
action
affect
variou
biolog
process
includ
cell
growth
differenti
signal
transduct
metabol
develop
inui
et
al
dysregul
mirna
express
describ
sever
diseas
role
appear
pivot
drive
tumorigenesi
iorio
croce
mirna
dysregul
consid
earli
event
tumorigenesi
cortez
et
al
discov
caenorhabd
elegan
nematod
dna
fragment
contain
small
sequenc
encod
rna
regul
transit
larval
stage
stage
regul
achiev
repress
express
protein
mirna
bind
noncod
region
utr
correspond
mrna
anoth
mirna
identifi
regul
transit
larval
stage
adult
stage
mechan
action
sinc
sever
discoveri
made
demonstr
conserv
mirna
sever
speci
studi
reveal
mirna
potenti
target
nearli
mrna
human
friedman
et
al
nucleu
gene
mirna
transcrib
primirna
action
rna
polymeras
type
ii
iii
borchert
et
al
yoonta
et
al
primirna
cleav
nuclear
microprocessor
complex
form
associ
enzym
drosha
digeorg
critic
region
protein
intermedi
precursor
call
premirna
han
et
al
complex
attach
primermirna
protein
allow
defin
cleavag
distanc
gener
measur
base
pair
junction
two
drosha
domain
cleav
end
primirna
result
premirna
loop
stem
two
unmatch
nucleotid
end
phosphat
end
asymmetri
specif
type
iii
rnase
premirna
migrat
cytoplasm
exportin
huang
et
al
garza
sotillo
thomastikhonenko
cytoplasm
premirna
undergo
anoth
stage
matur
rlc
risc
load
complex
compos
rnasedic
acytoplasm
endonucleas
perform
second
stage
process
includ
lead
strand
mir
passeng
strand
mir
mirna
high
degre
complementar
throughout
loop
stem
addit
cleavag
middl
strand
effect
trite
activ
protein
cleav
enzym
dicer
order
gener
acpremirna
precursor
mirna
eulalio
et
al
result
mirna
form
risc
complex
one
two
strand
call
passeng
strand
degrad
wherea
strand
least
stabl
end
call
guid
strand
retainedit
matur
mirna
evid
shown
strand
unstabl
weaker
base
pair
lower
chanc
degrad
sotillo
thomastikhonenko
fig
although
new
establish
method
revers
transcript
quantit
pcr
rtqpcr
use
detect
viral
infect
still
lack
robust
biomark
earli
diagnosi
prognosi
infecti
diseas
increas
evid
indic
cell
free
mirna
present
bodi
fluid
includ
blood
saliva
produc
endogen
respons
molecular
chang
cell
therefor
use
diagnost
report
variou
diseas
cancer
viral
infect
zhu
et
al
mirna
class
small
nucleotid
length
noncod
rna
involv
gene
regul
play
import
role
cell
prolifer
differenti
apoptosi
tumorigenesi
kaladhar
previou
report
mirna
distinct
express
profil
virusinfect
cell
comparison
healthi
counterpart
tambyah
et
al
zhu
et
al
moreov
express
level
mani
mirna
virusinfect
sampl
normal
control
exhibit
fold
chang
differ
song
et
al
studi
show
addit
regul
multipl
process
mirna
may
independ
effector
innat
immun
directli
target
viral
transcript
vitro
studi
show
mirna
target
influenza
vesicular
stomat
viru
human
tcell
leukemia
viru
human
papillomaviru
enteroviru
inhibit
viral
replic
fig
facilit
clearanc
potenti
viral
latenc
pathogen
bai
nicot
hen
et
al
zheng
et
al
mirna
also
essenti
show
malaria
transcript
transloc
parasit
inde
due
target
viral
transcript
mirna
potenti
partial
dictat
cell
tropism
viru
resist
rest
tcell
human
tcell
leukemia
viru
appear
due
express
rna
polymeras
ii
produc
nucleotid
transcript
call
primirna
matur
premirna
hairpin
drosha
nucleotid
doublestrand
hairpin
structur
export
nucleu
cytoplasm
exportin
ran
gtpase
lastli
premirna
process
produc
sens
antisens
strand
approxim
nucleotid
length
effect
strand
call
antisens
known
matur
mirna
shortliv
complementari
sequenc
call
passeng
strand
mir
antisensestrand
mirna
combin
risc
target
target
untransl
region
mrna
sequenc
facilit
repress
cleavag
aa
poli
tail
cap
mirna
microrna
orf
open
read
frame
rna
ribonucl
acid
bai
nicot
although
scientist
agre
direct
interact
mirna
viral
transcript
bogerd
et
al
argu
cellular
mirna
target
virus
global
downregul
host
cell
mirna
via
dicer
knockout
lead
enhanc
virus
human
embryon
kidney
cell
line
howev
bogerd
et
al
model
problemat
virus
may
depend
cell
mechan
control
mirna
usual
host
cell
virus
studi
human
embryon
kidney
cell
contrari
bogerd
et
al
studi
evid
direct
target
viral
genometranscript
occur
vivo
sever
group
success
attenu
viral
vaccin
incorpor
human
mirna
seed
site
viral
genom
see
clinic
applic
mirna
improv
vaccin
barn
et
al
rel
import
mirna
direct
target
virus
innat
immun
remain
seen
howev
vivo
vitro
studi
show
viral
mutat
mirna
seed
site
viral
genom
mean
virus
quickli
evolv
avoid
target
mirna
zheng
et
al
heiss
et
al
anoth
categori
mirna
secret
cell
call
extracellular
mirna
exmirna
circul
mirna
exmirna
isol
biolog
fluid
de
candia
et
al
irmak
et
al
weber
et
al
often
find
exmirna
extracellular
vesicl
exosom
microvesicl
apoptot
bodi
associ
argonaut
protein
compon
risc
complexse
fig
highdens
lipoprotein
de
candia
et
al
arroyo
et
al
vicker
et
al
zerneck
et
al
biolog
function
debat
sinc
secret
may
activ
intercellular
commun
gene
regul
cellular
wast
dispos
method
passiv
secret
byproduct
cell
death
turchinovich
cho
although
three
theori
valid
increas
evid
exmirna
function
pass
leukocyt
vitro
vivo
play
role
diseas
alexand
et
al
bell
taylor
lehmann
et
al
mittelbrunn
et
al
regardless
function
one
clinic
applic
exmirna
use
biomark
infecti
diseas
furthermor
mirna
shown
potenti
use
biomark
prognosi
therapi
infecti
diseas
mirna
also
shown
significantli
alter
express
infect
alter
express
mirna
level
infect
human
identifi
use
advanc
diagnost
tool
addit
avail
numer
bodi
fluid
mirna
highli
stabl
fluid
featur
make
mirna
singl
combin
peng
et
al
ideal
suit
biomark
diseas
diagnosi
present
standard
procedur
avail
isol
character
specif
mirna
experiment
research
observ
shown
small
interf
rna
prematur
mirna
transfer
rna
may
interfer
specif
mirna
process
isol
character
therefor
interfer
lead
falseposit
result
taken
care
diagnosi
necess
larg
amount
rna
input
northern
blot
techniqu
gener
difficulti
quantif
mirna
rtqpcr
microarray
profil
nextgener
sequenc
found
use
identif
novel
mirna
experienc
research
good
knowledg
molecular
biolog
well
bioinformat
character
mirna
immunomodulatori
function
mirna
repres
promis
applic
mirna
target
promot
antimicrobi
pathway
infect
control
dysregul
inflammatori
respons
sepsi
lung
mice
infect
nontyp
haemophilu
influenza
hock
et
al
note
physiolog
downregul
promot
phagocytosi
neutrophil
macrophag
bacteri
kill
found
boost
downregul
intratrach
administ
antagomir
enhanc
bacteri
kill
made
challeng
nontyp
h
influenza
anoth
case
alexand
et
al
observ
mice
inflammatori
respons
endotoxin
vivo
amelior
enhanc
administr
exosom
contain
respect
prompt
author
conclud
treatment
could
use
adjunct
manag
sepsi
case
vaccin
case
moreov
anoth
work
wang
et
al
support
idea
mirna
use
diseas
therapi
especi
sepsi
administr
mesenchym
stem
cell
exosom
contain
confer
cardiac
protect
septic
mice
overal
use
mirnabas
therapi
leverag
immun
respons
may
prove
use
adjunct
standard
antimicrobi
therapi
exampl
multidrugresist
gramneg
infect
chronic
viral
infect
hepat
c
nevertheless
signific
challeng
implement
mirnabas
antimicrobi
therapeut
includ
devis
method
administr
drug
design
protect
mirna
mimicsantagomir
circul
rnase
enzym
deliveri
system
ensur
target
effici
deliveri
mirna
site
infect
note
earlier
mirna
may
appear
mani
cell
type
serv
differ
function
make
offtarget
effect
real
possibl
limit
efficaci
safeti
chen
et
al
detail
analysi
outcom
phase
trial
two
mirnabas
cancer
treatment
provid
import
data
feasibl
mirnabas
therapeut
gener
beg
et
al
reid
et
al
note
earlier
trial
viral
mutat
resist
issu
need
tackl
van
der
ree
et
al
class
exmirna
ideal
biomark
candid
due
possibl
isol
biolog
fluid
boon
vicker
molecular
method
rtpcr
alreadi
use
routin
clinic
set
quickli
identifi
infect
eg
respiratori
infect
babi
bronchiol
could
use
quantifi
exmirna
patient
sampl
search
literatur
identifi
studi
assess
exmirna
infecti
diseas
whole
micronom
profil
candid
mirna
approach
thu
huge
major
work
base
serum
plasma
exmirna
cerebrospin
fluid
csf
saliva
sputum
also
implic
studi
focus
hcv
hepat
b
viru
hiv
tb
sepsi
aim
improv
diagnosi
prognost
infect
outcom
eg
death
sepsi
liver
cirrhosi
hepat
treatment
respons
infect
studi
base
comparison
exmirna
profil
patient
healthi
control
mani
studi
identifi
express
exmirna
highli
predict
infect
studi
zhang
et
al
found
differenti
express
pulmonari
tb
healthi
control
high
sensit
specif
go
respect
limit
healthi
control
use
comparison
differenti
express
exmirna
may
repres
nonspecif
marker
infect
lead
limit
clinic
translat
studi
given
peopl
undergo
test
symptomat
diseas
process
although
solv
problem
hand
studi
chosen
pragmat
compar
group
promisingli
suggest
exmirna
signatur
differenti
particular
infecti
diseas
differenti
diagnos
furthermor
promis
applic
exmirna
biomark
work
may
differenti
viral
bacteri
infect
identifi
prognost
sepsi
monitor
respons
antimicrobi
treatment
substanti
interstudi
discrep
mirna
identifi
potenti
biomark
may
due
heterogen
studi
design
eg
data
normal
method
confound
hospit
differ
defin
sepsi
icu
admiss
criteria
differ
length
ill
patient
creat
nois
data
longitudin
studi
measur
serial
mirna
level
would
provid
tempor
inform
mirna
express
sepsi
may
resolv
conflict
find
howev
challeng
use
mirna
biomark
infecti
diseas
underlin
lack
interstudi
cross
valid
mani
result
conflict
studi
result
may
aris
heterogen
studi
design
includ
differ
popul
control
group
method
mirna
extract
circul
fraction
investig
serum
plasma
microvesicl
exosom
micronom
express
profil
platform
nextgener
sequenc
probebas
hybrid
microarray
rtpcr
array
dearth
mirna
assess
limit
statist
power
mani
studi
profil
stage
data
normal
method
whether
pvalu
adjust
take
account
multipl
test
issu
usual
done
whether
confirmatori
cohort
use
valid
result
given
good
evid
mirna
contain
exosom
function
secret
intercellular
mediat
gene
regul
tempt
specul
biomark
studi
profil
mirna
exosom
rather
exmirna
total
plasmaserum
includ
background
mirna
present
dead
cell
could
sensit
specif
biomark
comparison
differ
extract
method
within
biomark
studi
could
help
resolv
possibl
previou
studi
report
mirna
play
import
role
influenza
interact
studi
fang
peng
et
al
mirna
express
profil
sera
patient
healthi
control
analyz
use
mirna
microarray
among
mirna
significantli
differenti
express
serum
sampl
compar
healthi
control
mirna
upregul
downregul
five
serum
mirna
candid
verifi
rtqpcr
receiv
oper
characterist
curv
analysi
perform
evalu
potenti
use
mirna
infect
diagnosi
serum
sampl
studi
mirna
microarray
assay
reveal
differenti
express
mirna
patient
serum
sampl
compar
healthi
control
identifi
five
mirna
use
diagnost
biomark
earli
detect
infect
mirna
signatur
advanc
understand
molecular
mechan
involv
influenza
infecti
diseas
rapid
accur
diagnosi
highli
transmiss
lethal
ill
ebola
viru
ebov
diseas
evd
critic
restrict
pathogen
spread
appli
appropri
therapeut
strategi
demonstr
recent
evd
outbreak
western
africa
earli
detect
confirm
suspect
case
essenti
halt
diseas
spread
blackley
et
al
current
diagnost
reli
identifi
ebov
blood
sampl
target
viral
antigen
use
enzym
immunoassay
amplifi
specif
viral
sequenc
quantit
revers
transcriptas
pcr
rtpcr
trombley
et
al
studi
janic
duy
et
al
author
analyz
express
circul
mirna
sequenc
archiv
plasma
rhesu
macaqu
expos
ebov
infect
either
intramuscular
inject
aerosol
inhal
identifi
mirna
show
signific
chang
abund
lethal
ebov
infect
group
found
mirna
correl
viral
titer
rhesu
macaqu
well
human
sampl
proof
concept
host
diagnost
identifi
eight
mirna
classifi
predict
acut
infect
high
accuraci
nonhuman
primat
human
classifi
identifi
half
presymptomat
macaqu
host
keep
caveat
asid
work
show
mirna
potenti
diagnost
candid
via
proof
concept
acut
evd
classifi
also
establish
potenti
basi
presymptomat
asymptomat
diagnosi
diseas
clinic
microbiolog
laboratori
local
level
increas
respons
provid
rapid
accur
diagnost
servic
emerg
new
reemerg
infecti
diseas
especi
diseas
signific
mortal
morbid
may
occur
result
delay
diagnosi
rapid
accur
diagnosi
emerg
reemerg
infecti
diseas
may
also
critic
local
level
ensur
optim
infect
control
detect
pathogen
often
requir
esoter
procedur
convent
pcr
could
perform
referr
laboratori
recent
public
health
laboratori
recent
technic
advanc
molecular
diagnost
result
develop
userfriendli
autom
test
platform
realtim
pcr
noveltest
method
use
detect
emerg
reemerg
pathogen
well
common
pathogen
potenti
broadscal
use
smaller
laboratori
close
proxim
deliveri
care
write
review
larg
outbreak
influenza
viru
type
peak
unit
state
new
influenza
viru
type
strain
associ
avian
human
influenza
region
far
east
appar
signific
morbid
mortal
associ
new
influenza
viru
strain
emphas
need
rapid
accur
laboratori
diagnost
capabl
local
level
case
sar
agent
bioterror
pathogen
rapid
diagnost
method
realtim
pcr
microarray
like
play
major
role
earli
sensit
detect
emerg
reemerg
infecti
diseas
encount
futur
otherwis
class
small
rna
implic
diagnosi
diseas
mirna
consid
essenti
mediat
host
respons
pathogen
sinc
sever
microb
evolv
exploit
pleiotrop
characterist
identif
key
gene
pathway
term
activ
enhanc
repress
silent
essenti
facilit
immun
respons
base
elucid
role
mirna
host
respons
infecti
diseas
complex
regulatori
network
within
mirna
embed
make
unpick
role
mirna
tough
imposs
integr
larg
mirna
mrna
dataset
use
advanc
statist
techniqu
system
biolog
approach
facilit
unpick
complex
network
overal
mirna
multipl
target
therefor
vaccin
treatment
har
mirna
may
produc
offtarget
effect
compromis
safeti
howev
challeng
must
overcom
object
improv
crossstudi
reproduc
find
especi
context
exmirna
biomark
identif
univers
endogen
control
need
standard
approach
biomark
studi
may
also
help
initi
devot
har
diagnost
therapeut
potenti
extracellular
rna
nation
institut
health
extracellular
commun
consortium
facilit
literatur
experiment
studi
mirna
develop
potenti
new
mirna
therapeut
diagnosticsprognost
vaccin
becom
tangibl
closer
translat
insight
mirna
studi
improv
live
patient
critic
next
step
